Semaglutide 2.4 mg (Wegovy) is approved in the United States, European Union, United Kingdom, Canada, Australia, and an expanding list of markets for chronic weight management in adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related comorbidity
A provider still needs to consider treatment goals, tolerability, side effects, cost, medical history, and how the womans body is responding over time
At Ilant, the start-up Elina founded, we have observed improvements across these areas, including reductions in loneliness
GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) and the dual GLP-1/GIP drug tirzepatide (Mounjaro/Zepbound) work by mimicking gut hormones that slow digestion, blunt appetite, and improve how your body handles blood sugar
They resist DPP-4 degradation, creating sustained receptor activation that lasts days (semaglutide has a half-life of approximately 168 hours)
Skin samples were fixed with 4% paraformaldehyde, embedded in paraffin, and sectioned for H&E, Masson, and immunohistochemical staining